Rhonda Farnum
Förmögenhet: 4 M $ per 2026-05-31
Förmögenhet: 4 M $ per 2026-05-31
Rhonda F.
Farnum is currently Chief Business Officer & SVP-Medical Affairs at Theravance Biopharma, Inc., a position held since 2021, with employment at the firm starting in 2018.
Formerly, Ms. Farnum was Head of the Hematology Business Unit at Onyx Pharmaceuticals, Inc. from 2014 to 2015.
Education includes undergraduate studies at the University of Georgia.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
THERAVANCE BIOPHARMA INC 0,48 % | 2026-05-20 | 245 771 ( 0,48 % ) | 4 M $ | 2026-05-31 |
| Företag | Position | Start |
|---|---|---|
| THERAVANCE BIOPHARMA, INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
| Företag | Position | Slut |
|---|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Företagsledare/Principal | 2015-08-01 |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 3 |
|---|---|
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Georgia
University of Georgia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theravance Biopharma, Inc.
Theravance Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of human therapeutics products for respiratory diseases | Health Technology |
Välj din utgåva
All finansiell information anpassad till den nationella nivån